BLOG

Failure blog post

Why are so many AI projects doomed for failure?

,
The elephant in the room is actually human By Shahar Cohen, PhD, Head of Verix AI Lab.   One of my first data science projects sought to improve the targeting process of a sales organization. Before we came in, sales reps were expected…

Bottom-up or Top-down Forecasting - Which Model Best Fits Your Needs?

,
Understanding HCPs’ prescribing behavior Vs. analyzing market trends. Demand forecast is key for sales and operations planning in the pharmaceutical industry. Naturally, a lot of time, money, and effort are invested in developing forecast…

Turn red roses into red alerts- How to detect anomalies before they affect your business

,
Have You Noticed There’s a Rosebush in Every Vineyard? Why and what can we learn from it? The picturesque 12th century Chateau Clos de Vougeot in Burgundy was famous for its prolific vineyards, maintained by local monks.  These monks realized…
Data: The Unlikely Star in a New ADHD Drug Launch

Data: The Unlikely Star in a New ADHD Drug Launch

,
In the whirlwind months leading up to a drug launch, data is just one of many concerns on pharma companies’ minds. But even before a new treatment gets into the hands of patients, companies with the right kind of advanced analytics…

How to Ride the Data Wave When Launching a New Drug

,
Some experts say that 50% of drug launches fail. Others say it’s as high as 90%. From my perspective, judging launches in such black-and-white terms isn’t particularly useful. Instead, I look at the market performance of a new drug…
Data collaboration through storiesVerix

Five different ways to tell your story

, ,
Accessible and actionable data are two basic stepping-stones for efficient data analyses. However, in today’s working environments, these are not enough, and to create truly successful working conditions that drive business growth, data…

What comes first, the problem or the solution?

,
Rather than spending months on requirements specifications followed by long, complicated implementations that by the time they’re ready to launch are already behind the eight ball, kick off a pilot initiative with the latest technology attainable…

Commercialising AI: Are We There Yet?

, , ,
The business case for wholesale adoption of AI doesn’t need to be made. But how far along is pharma? Advanced analytics and machine learning are the words on everyone’s lips in pharma right now. Companies big and small are…

P&G eliminated $250M of
non-productive inventory
in its first year with Verix

, ,
Listen to Andy Walter's, former Procter and Gamble head of IT, innovation spotlight at PharmaForce 2017, about analytics transformation. “We eliminated $250M of non-productive inventory in the first year of our analytic transformation with…